| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Executive Chairman
2 companies
Martin John C is a Director at GILEAD SCIENCES, INC. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 22 sells.
Estimated insider holdings value: $364.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 3, 2018 | GILD Gilead Sciences, Inc. | Director | Sale+OE | 50,000 | $71.20 | $3,560,178.15 | -0.6% | |
| Nov 1, 2018 | GILD Gilead Sciences, Inc. | Director | Sale+OE | 50,000 | $69.55 | $3,477,617.30 | -0.5% | |
| Oct 1, 2018 | GILD Gilead Sciences, Inc. | Director | Sale+OE | 50,000 | $78.04 | $3,902,209.79 | -0.8% | |
| Sep 4, 2018 | GILD Gilead Sciences, Inc. | Director | Sale+OE | 50,000 | $74.16 | $3,708,033.84 | -0.8% | |
| Aug 1, 2018 | GILD Gilead Sciences, Inc. | Director | Sale+OE | 50,000 | $77.85 | $3,892,650.00 | -1.6% | |
| Jul 2, 2018 | GILD Gilead Sciences, Inc. | Director | Sale+OE | 50,000 | $70.81 | $3,540,282.31 | -0.8% | |
| Jun 1, 2018 | GILD Gilead Sciences, Inc. | Director | Sale+OE | 50,000 | $68.13 | $3,406,495.00 | -1.6% | |
| May 1, 2018 | GILD Gilead Sciences, Inc. | Director | Sale+OE | 50,000 | $72.19 | $3,609,660.00 | -1.6% | |
| Apr 2, 2018 | GILD Gilead Sciences, Inc. | Director | Sale+OE | 50,000 | $73.14 | $3,656,805.61 | -0.4% | |
| Mar 1, 2018 | GILD Gilead Sciences, Inc. | Executive Chairman | Sale+OE | 50,000 | $78.65 | $3,932,375.01 | -0.5% |